Sensei Biotherapeutics, Inc. - COM (SNSE) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2021 to Q2 2025

Type / Class
Equity / COM
Symbol
SNSE on Nasdaq
Price per share
$0.30
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of Sensei Biotherapeutics, Inc. - COM (SNSE) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q2 0 $0 -$753,642 $0.30 0
2025 Q1 1,912,950 $753,705 -$200,699 $0.39 19
2024 Q4 2,364,130 $1,157,931 -$69,946 $0.49 24
2024 Q3 2,206,817 $1,319,693 +$63,592 $0.60 19
2024 Q2 2,107,576 $1,306,204 -$551,884 $0.62 23
2024 Q1 2,309,379 $2,425,234 -$649,432 $1.05 24
2023 Q4 2,962,310 $2,049,732 -$112,090 $0.69 23
2023 Q3 3,109,261 $2,380,834 -$22,423 $0.80 22
2023 Q2 3,143,573 $3,583,197 -$33,093 $1.14 25
2023 Q1 3,135,925 $4,708,416 +$725,044 $1.50 26
2022 Q4 2,640,954 $3,934,678 -$405,909 $1.49 27
2022 Q3 2,883,525 $4,466,935 -$415,491 $1.55 27
2022 Q2 3,110,355 $7,059,000 -$1,019,170 $2.27 31
2022 Q1 3,551,152 $8,214,000 +$152,668 $2.31 40
2021 Q4 3,405,229 $19,718,000 -$2,259,836 $5.80 36
2021 Q3 3,528,451 $37,065,000 +$12,940,421 $10.52 39
2021 Q2 2,322,732 $22,659,000 -$11,360,859 $9.76 34
2021 Q1 3,154,613 $45,797,000 +$45,797,000 $14.53 40